Doug Kass

Recommended Viewing

Nov 29, 2016 |   3:51 PM EST

Jim Cramer's Latest Post

Cramer: Rally Isn't Because Trump's Coming In but Because Fed's Going Out
Nov 29, 2016 |   2:24 PM EST

OPTIONS PROFITS

Setup de Resistance: Intel Call Spread
By

Timothy Collins

 | Nov 29, 2016  | 12:23 PM EST

Technical Corner

Tiffany's Charts Are Shining Bright
By

Bruce Kamich

 | Nov 29, 2016  | 2:35 PM EST

Featured Commentary

Carley Garner

Why Gold's Lost Sheen Should Be Temporary

By

Carley Garner

 | 3:00 PM EST | 
Not only is a new administration coming in but Janet Yellen is on the clock.
Bret Jensen

Banks, Oils Should Be Trump Winners in 2017

By

Bret Jensen

 | 1:00 PM EST | 
But first there might be profit taking in the financial and energy sectors amid recent moves higher.
Gary Morrow

JD.com Is a Top Gainer

By

Gary Morrow

 | 12:31 PM EST | 
Shares of the Chinese online direct sales company now have a very solid base.
Timothy Collins

Setup de Resistance: Intel Call Spread

By

Timothy Collins

 | 12:23 PM EST | 
With INTC coming into resistance and susceptible to a pullback, consider this bearish spread.

More Trading Strategies

RMPIA

Facebook's New Gaming Platform Could Eventually Prove Lucrative

By

Eric Jhonsa

 | Nov 29, 2016 | 7:41 PM EST |
Though not being immediately monetized, Facebook's Instant Games could help the company halt a multi-year decline in...

Mild Selloff Belies Poor Sub-Surface Action

By

James "Rev Shark" DePorre

 | Nov 29, 2016 | 4:22 PM EST |
The market is in need of a rest. Badly.

Why Gold's Lost Sheen Should Be Temporary

By

Carley Garner

 | Nov 29, 2016 | 4:00 PM EST |
Not only is a new administration coming in but Janet Yellen is on the clock.

Tiffany's Charts Are Shining Bright

By

Bruce Kamich

 | Nov 29, 2016 | 2:35 PM EST |
Buyers of Tiffany's shares have been more aggressive for about the last five months.
RMPIA

Cramer: Rally Isn't Because Trump's Coming In but Because Fed's Going Out

By

Jim Cramer

 | Nov 29, 2016 | 2:24 PM EST |
Market should still be able to breathe once central-bank prop is removed.

Survey Says... More Bank M&A on the Way in 2017

By

Tim Melvin

 | Nov 29, 2016 | 2:00 PM EST |
Shopping for potential targets in the Mid-Atlantic and Southeast makes sense.

Shark Bites: Eager Buyers Pounce on Pullback

By

James "Rev Shark" DePorre

 | Nov 29, 2016 | 1:52 PM EST |
I'm underinvested, which isn't good when indices are up.

More Base Building Ahead for Vertex Pharmaceuticals

By

Bruce Kamich

 | Nov 29, 2016 | 1:34 PM EST |
Buy signals have not lasted more than two months, so far.

Shocker! Why the Italian Referendum Could Be a Big Surprise

By

Mike Norman

 | Nov 29, 2016 | 1:00 PM EST |
And how to play it into the December 4 vote.

Italian Bonds Look Good Ahead of Key Vote

Nov 29, 2016 | 12:40 PM EST |
Sovereign debt offers a possible hedge to Sunday's constitutional referendum.

What Trump's Team Means for Bonds

By

Tom Graff

 | Nov 29, 2016 | 12:00 PM EST |
What economic policy under the incoming administration could mean, and how to play it.
RMPIA

Where Do Stock Prices Go From Here?

By

Sham Gad

 | Nov 29, 2016 | 12:00 PM EST |
At some point, this market optimism will falter, and investors should be prepared.

BioMarin Surging Beneath the Surface

By

Bruce Kamich

 | Nov 29, 2016 | 11:58 AM EST |
The pharmaceutical stock is about to go from sideways to up.

Beware Paralysis by Analysis

By

Timothy Collins

 | Nov 29, 2016 | 11:34 AM EST |
Charting performance among asset classes offers quick, visual clues to diversification.

Novice Trade: Facebook

By

Mark Sebastian

 | Nov 29, 2016 | 11:33 AM EST |
Take this selloff as an opportunity to dip into FB long-term calls again.
See all headlines »

Upgrades & Downgrades

VRTX
Bearish

Vertex downgraded at Barclays

Nov 29, 2016 | 7:50 AM EST
VRTX was downgraded from Overweight to Equal-weight, Barclays said. $90 price target. Company has an uncertain clinical profile.
ALXN
Bullish

Alexion upgraded at Barclays

Nov 29, 2016 | 7:48 AM EST
ALXN was upgraded from Equal-weight to Overweight, Barclays said. $155 price target. Company has multiple potential catalysts for 2017.…
PFE
Bullish

Pfizer upgraded at Barclays

Nov 29, 2016 | 7:47 AM EST
PFE was upgraded from Equal-weight to Overweight, Barclays said. $38 price target. Company should be able to use foreign cash to boost …
JNJ
Bearish

Johnson & Johnson downgraded at Barclays

Nov 29, 2016 | 7:45 AM EST
JNJ was downgraded from Overweight to Equal-weight, Barclays said. Valuation call, based on a $125 price target.
N
Update

Consumer Confidence

Nov 29, 2016 | 7:43 AM EST
10am: Consumer Confidence Index, Nov., est. 101.5 (prior 98.6)
See More »

Columnist Conversations

Gary Morrow:  
Caterpillar Looking Vulnerable
CAT is showing signs of upside exhaustion.  The stock has been struggling with heavy ...
David Katz:  
TE CONNECTIVITY - More of the same (and that's a good thing).
At an investment conference on Tuesday, TE Connectivity's (TEL) incoming CEO and current p...
David Katz:  
Qualcomm Update from the CSFB Technology, Media & Telecom Conference.
Qualcomm (QCOM) spoke at the CSFB Technology, Media and Telecom conference this afternoon....
Robert Lang:  
Roll Up XLNX Calls
we'll roll this winner up to March SOLD XLNX JAN 50 CALL AT 4.70 (IN AT 3....
See more »
RMPIA
RMPIA TODAY
RMPIA Year-to-Date:
SEE COMPONENTS »

REAL MONEY PRO'S BEST IDEAS

SEE MORE»

News Breaks

Powered by
See More ยป
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.